This Article Full Text Full Text (PDF) All Versions of this Article: 90/5/2500    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, S.-H. Articles by Cheng, C.-J. Search for Related Content PubMed PubMed Citation Articles by Lin, S.-H. Articles by Cheng, C.-J. Pubmed/NCBI databases Protein Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL Medline Plus Health Information Nutrition Related Collections Metabolism

Phenotype and Genotype Analysis in Chinese Patients with Gitelman’s Syndrome

Division of Nephrology (S.-H.L., S.-S.Y., Y.-J.H., C.-J.C.), Department of Medicine, Tri-Service General Hospital, Neihu 114, Taipei, Taiwan; Division of Nephrology (J.-C.S.), Department of Medicine, Kaohsiung Army General Hospital, Lin-Ya 802 Kaohsiung, Taiwan; and Department of Biochemistry (C.-C.H.), Neihu 114 National Defense Medical Center, Taipei, Taiwan

Address all correspondence and requests for reprints to: Shih-Hua Lin, M.D., Division of Nephrology, Department of Medicine, Tri-Service General Hospital, Number 325, Section 2, Cheng-Kung Road, Neihu 114, Taipei, Taiwan. E-mail: shihhualin{at}yahoo.com.

Inactivation mutations of the luminal thiazide-sensitive NaCl cotransporter (NCC) in the distal convoluted tubules or the basolateral chloride channel (CLCNKB) in the distal nephron are the most common genetic mutations in Gitelman’s syndrome (GS) or Bartter’s syndrome (BS). We conducted clinical and molecular studies in Chinese patients with GS or BS. Twenty patients with chronic hypokalemia (15 males and five females, age 25 ± 7 yr) from 15 unrelated Chinese families were investigated. All had renal K⁺ wasting, metabolic alkalosis, and normotension. The urinary calcium excretion rate was used to distinguish between BS or GS on clinical grounds. Clinical symptoms and biochemical studies were recorded. Molecular analysis included PCR single-strand confirmational polymorphism, direct sequencing of both the NCC and CLCNKB genes, and restriction fragment length polymorphism. Sixteen patients had a clinical diagnosis of GS with hypocalciuria and four BS without hypocalciuria. Four of these 20 patients did not have hypomagnesemia. The males had severe hypokalemia [1.9 ± 0.4 mEq/liter (mmol/liter)] with paralytic episodes, whereas females had moderate hypokalemia [2.6 ± 0.2 mEq/liter (mmol/liter)] and less severe symptoms. There were no mutations detected in CLCNKB. Twelve NCC mutations, including six novel mutations and nine recurrent ones, were identified. Allele frequency of the detected NCC mutations was 3% in 100 healthy subjects. Some GS patients with NCC mutations may have normocalciuria and/or normomagnesemia. Gender differences may account for phenotype variability. Screening of these identified NCC mutations remains the gold standard for the diagnosis of GS.

This article has been cited by other articles:

				E. Riveira-Munoz, Q. Chang, N. Godefroid, J. G. Hoenderop, R. J. Bindels, K. Dahan, O. Devuyst, and for the Belgian Network for the Study of Gitelman Transcriptional and Functional Analyses of SLC12A3 Mutations: New Clues for the Pathogenesis of Gitelman Syndrome J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1271 - 1283. [Abstract] [Full Text] [PDF]

				H. -Y. Ng, S. -H. Lin, C. -Y. Hsu, Y. -Z. Tsai, H. -C. Chen, and C. -T. Lee Hypokalemic paralysis due to Gitelman syndrome: A family study. Neurology, September 26, 2006; 67(6): 1080 - 1082. [Abstract] [Full Text] [PDF]